Interaction between platelets and endothelium: from pathophysiology to new therapeutic options

Area of Science:

• Cardiovascular Medicine
• Hematology
• Vascular Biology

Background:

• Platelets were historically viewed solely for hemostasis but are now recognized for roles in vasomotor function, inflammation, and atherosclerosis.
• Endothelium, once a passive barrier, is now understood as a vital organ for vascular health; its dysfunction initiates vascular disease.
• Platelet-endothelial interactions significantly contribute to the initiation and progression of vascular diseases.

Purpose of the Study:

• To review the evolving understanding of platelet function beyond hemostasis.
• To explore the role of platelet-endothelium interactions in vascular disease.
• To discuss the multifaceted benefits of current antiplatelet therapies, particularly newer agents like ticagrelor.

Main Methods:

• Literature review of established and recent research on platelet biology and vascular endothelium.
• Analysis of clinical evidence supporting the efficacy of antiplatelet agents in coronary artery disease.
• Examination of proposed mechanisms for the anti-inflammatory and other non-antithrombotic effects of antiplatelet drugs.

Main Results:

• Platelet roles in inflammation, vasomotor function, and atherosclerosis are increasingly recognized.
• Endothelial dysfunction and platelet hyper-reactivity are independent risk factors for cardiovascular events.
• Current antiplatelet agents, especially ticagrelor, provide benefits through antithrombotic and anti-inflammatory actions.

Conclusions:

• Platelet-endothelium interactions are critical in vascular health and disease.
• Modern antiplatelet therapies offer benefits beyond simple antithrombotic effects.
• Further research is needed to fully elucidate platelet-endothelium interactions and the comprehensive impact of antiplatelet therapy.